Pancreatic Cancer Research

ResearcherCross Cancer InstituteNo recent work listed

Jennifer L. Spratlin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3304-1784; OpenAlex author ID A5008288310. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 2, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2011: 1 paper, 1 trial · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 6

  1. Changing Rates of Goals of Care Designations in Patients With Advanced Pancreatic Cancer During a Multifactorial Advanced Care Planning Initiative: A Real-Worl… Last author DOI 10.1200/op.21.00649↗
  2. Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma. First author DOI 10.1007/s12032-021-01469-y↗
  3. Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic Cancer. First author DOI 10.1097/coc.0000000000000625↗
  4. Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta. Last author DOI 10.1097/coc.0000000000000385↗
  5. Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic canc… Co-author DOI 10.1093/annonc/mdt066↗
  6. Looking to the future: biomarkers in the management of pancreatic adenocarcinoma. Co-author DOI 10.3390/ijms12095895↗

Trials 1

  1. Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer Principal investigator NCT01411072↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Winson Y. Cheung · 2 shared papers, 2019–2022 · strength 0.29
  2. Omar Mohammed Abdel-Rahman · 1 shared paper, 2021 · strength 0.22
  3. Sheryl L. Koski · 1 shared paper, 2021 · strength 0.22
  4. Christina Kim · 2 shared papers, 2018–2019 · strength 0.21
  5. Matthew Anaka · 1 shared paper, 2022 · strength 0.19
  6. Sharlene Gill · 1 shared paper, 2019 · strength 0.11
  7. Erica S. Tsang · 1 shared paper, 2019 · strength 0.11
  8. Karen E. Mulder · 1 shared paper, 2011 · strength 0.06
  9. Denis Pezet · 1 shared paper, 2013 · strength 0.03
  10. Caio Rocha‐Lima · 1 shared paper, 2013 · strength 0.03
  11. Eileen Mary O'Reilly · 1 shared paper, 2013 · strength 0.03
  12. Emily W. Chan · 1 shared paper, 2013 · strength 0.03
  13. Lawrence Scott Blaszkowsky · 1 shared paper, 2013 · strength 0.03
  14. Manuel M. Hidalgo · 1 shared paper, 2013 · strength 0.03
  15. Brian Matthew Wolpin · 1 shared paper, 2013 · strength 0.03
  16. Teresa Mercade Macarulla · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.